KHA Releases One-Pager Supporting SB 27

Share

Protect Private Money Providing Patient Access

The 340B drug discount program is a privately funded, federally administered system. The program allows non-profit, safety-net hospitals to purchase outpatient medications from pharmaceutical manufacturers at the same price the manufacturers charge their best customers – NOT for free.

Pharmaceutical manufacturers, which continue to have record profits, agreed to fund the 340B program in order to be a part of Obamacare. Now they want to back out of that commitment. Their refusal to ship prescription drugs comes at the expense of the poorest and most vulnerable patients being served by 340B hospitals.

The savings from the program help Kentucky hospitals to maintain access to care and make it possible for hospitals to offer additional services to their patients.

Latest News

News Podcast
February 27, 2026
University of Louisville Professor of Pediatrics and practicing neonatologist with the Norton Children's Medical Group Dr. Lori Devlin joins the podcast.
News
February 17, 2026
This year’s conference, hosted by Mississippi, is August 5-7 in New Orleans.
News
February 6, 2026
Several times a year, KHA releases an e-newsletter with updates and information on Workforce projects and initiatives affecting KHA member hospitals.